Zentalis Pharmaceuticals, LLC Contracts & Agreements
73 Contracts & Agreements
- Business Finance (14 contracts)
- Business Formation (2)
- Business Operations (2)
- Human Resources (32)
- Intellectual Property (4)
- Real Estate (10)
- Uncategorized (9)
- Non-Employee Director Compensation Program (Filed With SEC on February 27, 2024)
- Third Amended and Restated License Agreement, dated June 5, 2023, by and between Zeno Management, Inc. and Recurium IP Holdings, LLC (Filed With SEC on August 9, 2023)
- Underwriting Agreement, dated June 1 (Filed With SEC on June 15, 2023)
- Form of Indemnification Agreement for Directors and Officers (Filed With SEC on May 10, 2023)
- Sublease, effective March 6, 2023, between Zentalis Pharmaceuticals, Inc. and L.M. Cohen & Co. LLP Certified Public Accountants, as amended on April 10, 2023 (Filed With SEC on May 10, 2023)
- Non-Employee Director Compensation Program (Filed With SEC on March 1, 2023)
- Amended and Restated Employment Agreement, effective as of (Filed With SEC on March 1, 2023)
- Amended and Restated (Filed With SEC on March 1, 2023)
- Amended and Restated (Filed With SEC on March 1, 2023)
- Amended and Restated (Filed With SEC on March 1, 2023)
- Amended and Restated Employment Agreement, dated February (Filed With SEC on March 1, 2023)
- Amended and Restated Employment Agreement, dated February (Filed With SEC on March 1, 2023)
- Compound Specific Patent Rights Amendment to the Second Amended and Restated License Agreement, dated March 17, 2022, by and between Zeno Management, Inc. and Recurium IP... (Filed With SEC on March 1, 2023)
- Employment Agreement, dated September 15, 2022, between Zeno Management, Inc. and Carrie Brownstein (Filed With SEC on November 9, 2022)
- Release Agreement, dated September 23, 2022. between Zentalis Pharmaceuticals, Inc. and Dimitris Voliotis (Filed With SEC on November 9, 2022)
- Amended and Restated Employment Agreement, dated September 26, 2022 between Zeno Management, Inc. and Kevin Bunker (Filed With SEC on November 9, 2022)
- Employment Agreement, dated June 23, 2022, between Zeno Management, Inc. and Andrea Paul (Filed With SEC on August 9, 2022)
- Zentalis Pharmaceuticals, Inc. 2022 Employment Inducement Incentive Award Plan (Filed With SEC on July 22, 2022)
- Form of Option Agreement pursuant to the Zentalis Pharmaceuticals, Inc. 2022 Employment Inducement Incentive Award Plan (Filed With SEC on July 22, 2022)
- Form of RSU Agreement pursuant to the Zentalis Pharmaceuticals, Inc. 2022 Employment Inducement Incentive Award Plan (Filed With SEC on July 22, 2022)
- Amended and Restated Employment Agreement, dated May 30, 2022, between Zeno Management, Inc. and Cam S. Gallagher (Filed With SEC on May 31, 2022)
- Employment Agreement, dated May 11, 2022, between Zentalis Pharmaceuticals, Inc. and Kimberly Blackwell, M.D (Filed With SEC on May 16, 2022)
- Release Agreement, dated May 10, 2022, between Zentalis Pharmaceuticals, Inc. and Anthony Y. Sun, M.D (Filed With SEC on May 16, 2022)
- Underwriting Agreement, dated May 16, 2022, by and among the Company and Morgan Stanley & Co. LLC, Jefferies LLC and SVB (Filed With SEC on May 16, 2022)
- Non-Employee Director Compensation Program (Filed With SEC on February 24, 2022)
- Underwriting Agreement, dated June 28, 2021, by and among the Company and Morgan Stanley & Co. LLC, Jefferies LLC and SVB Leerink LLC, as representatives of the several... (Filed With SEC on July 1, 2021)
- Amendment No. 1 to the Zentalis Pharmaceuticals, Inc. 2020 Incentive Award Plan (Filed With SEC on May 17, 2021)
- Lease, effective March 24, 2021, between Zentalis Pharmaceuticals, Inc. and ESRT 1359 Broadway, L.L.C (Filed With SEC on May 17, 2021)
- Description of Capital Stock (Filed With SEC on March 25, 2021)
- Non-Employee Director Compensation Program (Filed With SEC on March 25, 2021)
- Lease, effective March 24, 2021, between Zentalis Pharmaceuticals, Inc. and ESRT 1359 BROADWAY, L.L.C (Filed With SEC on March 25, 2021)
- Employment Agreement, effective as of October 1, 2020, between Zeno Management, Inc. and Cam Gallagher (Filed With SEC on November 9, 2020)
- Employment Agreement, effective as of July 20, 2020, between Zeno Management, Inc. and Alexis Pinto (Filed With SEC on November 9, 2020)
- Lease, effective September 30, 2020, between Zentalis Pharmaceuticals, Inc. and TPSC IX, LLC (Filed With SEC on October 2, 2020)
- Second Amended and Restated Employment Agreement, effective as of October 1, 2020, between Zeno Management, Inc. and Anthony Y. Sun, M.D (Filed With SEC on October 2, 2020)
- Amended and Restated Employment Agreement, effective as of October 1, 2020, between Zeno Management, Inc. and Kevin Bunker, Ph.D (Filed With SEC on October 2, 2020)
- Amended and Restated Employment Agreement, effective as of October 1, 2020, between Zeno Management, Inc. and Melissa Epperly (Filed With SEC on October 2, 2020)
- Greater China Amendment to the Second Amended and Restated License Agreement, dated May 19, 2020, by and between Zeno Management, Inc. and Recurium IP Holdings, LLC (Filed With SEC on August 13, 2020)
- Agreement for Termination of Lease and Voluntary Surrender of Premises, dated July 27, 2020, by and between Zeno Management, Inc. and ARE-SD-Region NO. 44, LLC (Filed With SEC on July 28, 2020)
- Form of Underwriting Agreement (Filed With SEC on July 27, 2020)
- Plan of Conversion (Filed With SEC on July 27, 2020)
- Certificate of Conversion of Zentalis Pharmaceuticals, LLC (Filed With SEC on July 27, 2020)
- Release Agreement by and between Zeno Management, Inc. and Robert Winkler, M.D (Filed With SEC on July 27, 2020)
- Plan of Conversion Converting Zentalis Pharmaceuticals, LLC (a Delaware limited liability company) into Zentalis Pharmaceuticals, Inc. (a Delaware corporation) (Filed With SEC on May 15, 2020)
- Certificate of Conversion Converting Zentalis Pharmaceuticals, LLC (a Delaware limited liability company) into Zentalis Pharmaceuticals, Inc. (a Delaware corporation) (Filed With SEC on May 15, 2020)
- Release Agreement, dated May (Filed With SEC on May 15, 2020)
- Form of Plan of Conversion (Filed With SEC on March 31, 2020)
- Form of Underwriting Agreement (Filed With SEC on March 30, 2020)
- Form of Plan of Conversion (Filed With SEC on March 30, 2020)
- Form of Certificate of Conversion of Zentalis Pharmaceuticals, LLC (Filed With SEC on March 30, 2020)
- 2020 Incentive Award Plan and form of option agreement and restricted stock unit agreement thereunder (Filed With SEC on March 30, 2020)
- Non-Employee Director Compensation Program (Filed With SEC on March 30, 2020)
- 2020 Employee Stock Purchase Plan (Filed With SEC on March 30, 2020)
- Form of Conversion Restricted Stock Award Agreement for former Class B Common Unit Holders (Filed With SEC on March 30, 2020)
- Form of Indemnification Agreement for Directors and Officers (Filed With SEC on March 30, 2020)
- Employment Agreement, dated March 25, 2020, by and between Zeno Management, Inc. and Dimitris Voliotis, M.D (Filed With SEC on March 30, 2020)
- Amended and Restated Investors Rights Agreement, dated as of September 6, 2019, by and among Zentalis Pharmaceuticals, LLC and the investors party thereto (Filed With SEC on March 6, 2020)
- Specimen Common Stock Certificate evidencing the shares of common stock (Filed With SEC on March 6, 2020)
- Zentalis Pharmaceuticals, LLC 2017 Profits Interest Plan, as amended, and form of profit interest award agreement thereunder (Filed With SEC on March 6, 2020)
- Lease Agreement, dated April 12, 2019, between Zeno Management, Inc. and G&S Realty 1, LLC (Filed With SEC on March 6, 2020)
- Sublease Agreement, dated September 16, 2019, between Zeno Management, Inc. and Lundbeck La Jolla Research Center, Inc (Filed With SEC on March 6, 2020)
- Lease Agreement, dated November 12, 2015, between the Registrant and BMR-Road to the Cure, LP (Filed With SEC on March 6, 2020)
- First Amendment to Lease Agreement, dated December 6, 2018, between the Registrant and BMR-Road to the Cure, LP (Filed With SEC on March 6, 2020)
- Lease Agreement, dated January 14, 2020, between Zeno Management, Inc. and ARE-SD Region NO. 44, LLC (Filed With SEC on March 6, 2020)
- Amended and Restated Employment Agreement, dated February 1, 2019, by and between Zeno Management, Inc. and Anthony Y. Sun, M.D (Filed With SEC on March 6, 2020)
- Amendment to Amended and Restated Employment Agreement, dated February 25, 2020, by and between Zeno Management, Inc. and Anthony Y. Sun, M.D (Filed With SEC on March 6, 2020)
- Employment Agreement, dated September 5, 2019, by and between the Zeno Management, Inc. and Melissa Epperly (Filed With SEC on March 6, 2020)
- Employment Agreement, dated February 1, 2019, by and between Zeno Management, Inc. and Kevin Bunker, Ph.D (Filed With SEC on March 6, 2020)
- Amendment to Employment Agreement, dated February 25, 2020, by and between Zeno Management, Inc. and Kevin Bunker, Ph.D (Filed With SEC on March 6, 2020)
- Employment Agreement, dated February 1, 2019, by and between Zeno Management, Inc. and Robert Winkler, M.D (Filed With SEC on March 6, 2020)
- Consulting Agreement, dated February 1, 2019, by and between Zeno Management, Inc. and Cam Gallagher (Filed With SEC on March 6, 2020)
- Amended and Restated Consulting Agreement, dated February 25, 2020, by and between Zeno Management, Inc. and Cam Gallagher (Filed With SEC on March 6, 2020)
- Second Amended and Restated License Agreement, dated September 6, 2019, between the Registrant and Recurium IP Holdings, LLC (Filed With SEC on March 6, 2020)
